US FDA approves Daiichi, AstraZeneca drug for treatment of solid tumors
(Reuters) – The U.S. Food and Drug Administration on Friday gave accelerated approval for the expanded use of Daiichi Sankyo and AstraZeneca’s drug to treat …
(Reuters) – The U.S. Food and Drug Administration on Friday gave accelerated approval for the expanded use of Daiichi Sankyo and AstraZeneca’s drug to treat …
By Divya Chowdhury and Savio Shetty DAVOS, Switzerland (Reuters) – Drugmaker AstraZeneca has not seen any supply issues so far due to Red Sea shipping …
(Reuters) – Shares in AstraZeneca fell more than 4% on Wednesday after the publication of an abstract on its experimental precision drug’s use in lung …
By Maggie Fick (Reuters) -AstraZeneca said on Friday its experimental precision drug had slowed the progression of a common type of breast cancer in a …
By Daniel Wiessner (Reuters) – AstraZeneca Pharmaceuticals LP has been sued in the U.S. by a former senior director who claims the drugmaker refused to …
(Reuters) – AstraZeneca said on Thursday that a combination of its cancer drug Lynparza and abiraterone has been approved in the United States for the …
FRANKFURT – Long-serving AstraZeneca boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take …
SEOUL – South Korea on Thursday authorised AstraZeneca PLC’s antibody-based therapy for preventing COVID-19 infection in people with a poor immune response, increasing its options …
By Natalie Grover LONDON – AstraZeneca and Daiichi Sankyo’s Enhertu extended survival by more than six months in patients with a form of advanced breast …